CBD is a cannabis extract that does not cause a high but is marketed as a healing remedy to alleviate conditions such as anxiety or chronic pain. The product’s regulation is so lax that even those in the industry have voiced concerns, the Chicago Tribune reported.
“We were really unnerved by the lack of consistency and regulation, and the wide variety of manufacturing processes that companies were using,” said Coco Meers, co-founder of Chicago-based CBD company Equilibria.
Meers said CBD products can contain harmful pesticides or heavy metals and may not have the promised amount of cannabidiol.
“At the end of the day, everything gets called CBD, but all CBD is not created equal,” Meers said.
Chicago-based LeafyQuick, a retailer of CBD products, only sells products that have been tested, said co-founder Rahul Easwar.
“When we tell them, ‘Hey, this is third-party tested,’ it’s more like, ‘OK great, but tell me what flavor you have,’” Easwar said. “It’s more of an afterthought or it’s not a thought at all.”
The bill would